Langston JW - Search Results

1

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Obeso JA, et al. Among authors: langston jw. Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Mov Disord. 2017. PMID: 28887905 Free PMC article. Review.

2

Core assessment program for intracerebral transplantations (CAPIT).

Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Langston JW, et al. Mov Disord. 1992;7(1):2-13. doi: 10.1002/mds.870070103. Mov Disord. 1992. PMID: 1557062 No abstract available.

3

Selegiline and mortality in Parkinson's disease.

Olanow CW, Fahn S, Langston JW, Godbold J. Olanow CW, et al. Among authors: langston jw. Ann Neurol. 1996 Dec;40(6):841-5. doi: 10.1002/ana.410400605. Ann Neurol. 1996. PMID: 9007088 Review. No abstract available.

4

Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease.

Chan P, Tanner CM, Jiang X, Langston JW. Chan P, et al. Among authors: langston jw. Neurology. 1998 Feb;50(2):513-4. doi: 10.1212/wnl.50.2.513. Neurology. 1998. PMID: 9484385

5

Do environmental toxins cause Parkinson's disease? A critical review.

Tanner CM, Langston JW. Tanner CM, et al. Among authors: langston jw. Neurology. 1990 Oct;40(10 Suppl 3):suppl 17-30; discussion 30-1. Neurology. 1990. PMID: 2215971 Review. No abstract available.

6

Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.

Kurth MC, Tetrud JW, Tanner CM, Irwin I, Stebbins GT, Goetz CG, Langston JW. Kurth MC, et al. Among authors: langston jw. Neurology. 1993 Sep;43(9):1698-703. doi: 10.1212/wnl.43.9.1698. Neurology. 1993. PMID: 8414015 Clinical Trial.

7

Selegiline and Parkinson's disease: it's déjà vu-again.

Langston JW, Tanner CM. Langston JW, et al. Neurology. 2000 Dec 26;55(12):1770-1. doi: 10.1212/wnl.55.12.1770. Neurology. 2000. PMID: 11134369 No abstract available.

8

Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease.

Chan P, Jiang X, Forno LS, Di Monte DA, Tanner CM, Langston JW. Chan P, et al. Among authors: langston jw. Neurology. 1998 Apr;50(4):1136-7. doi: 10.1212/wnl.50.4.1136. Neurology. 1998. PMID: 9566408

9

CYP2D6 allelic frequencies in young-onset Parkinson's disease.

Sandy MS, Armstrong M, Tanner CM, Daly AK, Di Monte DA, Langston JW, Idle JR. Sandy MS, et al. Among authors: langston jw. Neurology. 1996 Jul;47(1):225-30. doi: 10.1212/wnl.47.1.225. Neurology. 1996. PMID: 8710083

10

Occupation and parkinsonism in three movement disorders clinics.

Goldman SM, Tanner CM, Olanow CW, Watts RL, Field RD, Langston JW. Goldman SM, et al. Among authors: langston jw. Neurology. 2005 Nov 8;65(9):1430-5. doi: 10.1212/01.wnl.0000180361.74060.70. Epub 2005 Sep 14. Neurology. 2005. PMID: 16162857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page